Clinical trial
Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast…
NCT00005886 · University of Kansas Medical Center, Other · Completed
Key facts
| NCT number | NCT00005886 |
|---|---|
| Title | Tamoxifen Compared With LY353381 in Treating Women With Newly Diagnosed Breast Cancer |
| Official title | A Phase IB Randomized Study of an Antiestrogen in Women With Newly Diagnosed Breast Cancer |
| Lead sponsor | University of Kansas Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | arzoxifene hydrochloride, tamoxifen citrate |
| Start date | Jul 1, 2000 |
| Primary completion | Aug 1, 2002 |
| Completion | Aug 1, 2002 |
| First posted | Aug 29, 2003 |
| Last update posted | Jan 13, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: